Structural features of antiviral DNA cytidine deaminases

Biological Chemistry

Volumn 394, Issue 11, 2013, Pages 1357-1370

  Vasudevan, Ananda Ayyappan Jaguva ^a   Smits, Sander H J ^a   Höppner, Astrid ^a   Häussinger, Dieter ^a   Koenig, Bernd W ^b   Münk, Carsten ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

APOBEC3G; HIV 1; Homology modeling; NMR; Vif; X ray

Indexed keywords

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3A; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3C; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3D; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3H; CYTIDINE DEAMINASE; GLOBULAR PROTEIN; OLIGOMER; UNCLASSIFIED DRUG;

ALPHA HELIX; BETA SHEET; COMPLEX FORMATION; CRYSTAL STRUCTURE; DNA STRUCTURE; DNA VIRUS; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN IMMUNODEFICIENCY VIRUS 1; NUCLEAR MAGNETIC RESONANCE; OLIGOMERIZATION; PRIORITY JOURNAL; REVIEW; X RAY CRYSTALLOGRAPHY;

CATALYSIS; CYTOSINE DEAMINASE; DNA, SINGLE-STRANDED; DNA, VIRAL; HUMANS; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RETROVIRIDAE; SCATTERING, SMALL ANGLE;

EID: 84883320506     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0165     Document Type: Review

References (82)

1. Albin, J.S. and Harris, R.S. (2010). Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics. Expert. Rev. Mol. Med 12, e4.
2. Albin, J.S., LaRue, R.S., Weaver, J.A., Brown, W.L., Shindo, K., Harjes, E., Matsuo, H., and Harris, R.S. (2010). A single amino acid in human APOBEC3F alters susceptibility to HIV-1 Vif. J. Biol. Chem. 285, 40785-40792.
3. Arias, J.F., Koyama, T., Kinomoto, M., and Tokunaga, K. (2012). Retroelements versus APOBEC3 family members: no great escape from the magnificent seven. Front. Microbiol. 3, 275.
4. Autore, F., Bergeron, J.R., Malim, M.H., Fraternali, F., and Huthoff, H. (2010). Rationalisation of the differences between APOBEC3G structures from crystallography and NMR studies by molecular dynamics simulations. PLoS One. 5, e11515.
5. Bennett, R.P., Salter, J.D., Liu, X., Wedekind, J.E., and Smith, H.C. (2008). APOBEC3G subunits self-associate via the C-terminal deaminase domain. J. Biol. Chem. 283, 33329-33336.
6. Bergeron, J.R., Huthoff, H., Veselkov, D.A., Beavil, R.L., Simpson, P.J., Matthews, S.J., Malim, M.H., and Sanderson, M.R. (2010). The SOCS-box of HIV-1 Vif interacts with ElonginBC by induced-folding to recruit its Cul5-containing ubiquitin ligase complex. PLoS Pathog. 6, e1000925.
7. Bohn, M.F., Shandilya, S.M., Albin, J.S., Kouno, T., Anderson, B.D., McDougle, R.M., Carpenter, M.A., Rathore, A., Evans, L., Davis, A.N., et al. (2013). Crystal structure of the DNA cytosine deaminase APOBEC3F: the catalytically active and HIV-1 Vif-binding domain. Structure 21, 1042-1050.
8. Bulliard, Y., Turelli, P., Rohrig, U.F., Zoete, V., Mangeat, B., Michielin, O., and Trono, D. (2009). Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionarily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition. J. Virol. 83, 12611-12621.
9. Burnett, A. and Spearman, P. (2007). APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker. J. Virol. 81, 5000-5013. (Pubitemid 46744412)
10. Burns, M.B., Lackey, L., Carpenter, M.A., Rathore, A., Land, A.M., Leonard, B., Refsland, E.W., Kotandeniya, D., Tretyakova, N., Nikas, J.B., et al. (2013). APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494, 366-370.
11. Byeon, I.J., Ahn, J., Mitra, M., Byeon, C.H., Hercik, K., Hritz, J., Charlton, L.M., Levin, J.G., and Gronenborn, A.M. (2013). NMR structure of human restriction factor APOBEC3A reveals substrate binding and enzyme specificity. Nat. Commun. 4, 1890.
12. Chareza, S., Slavkovic, L.D., Liu, Y., Rathe, A.M., Münk, C., Zabogli, E., Pistello, M., and Löchelt, M. (2012). Molecular and functional interactions of cat APOBEC3 and feline foamy and immunodeficiency virus proteins: different ways to counteract host-encoded restriction. Virology 424, 138-146.
13. Chelico, L., Pham, P., Calabrese, P., and Goodman, M.F. (2006). APOBEC3G DNA deaminase acts processively 3'→5' on single-stranded DNA. Nat. Struct. Mol. Biol 13, 392-399. (Pubitemid 43881578)
14. Chelico, L., Sacho, E.J., Erie, D.A., and Goodman, M.F. (2008). A model for oligomeric regulation of APOBEC3G cytosine deaminase-dependent restriction of HIV. J. Biol. Chem. 283, 13780-13791.
15. Chelico, L., Prochnow, C., Erie, D.A., Chen, X.S., and Goodman, M.F. (2010). Structural model for deoxycytidine deamination mechanisms of the HIV-1 inactivation enzyme APOBEC3G. J. Biol. Chem. 285, 16195-16205.
16. Chen, K.M., Harjes, E., Gross, P.J., Fahmy, A., Lu, Y., Shindo, K., Harris, R.S., and Matsuo, H. (2008). Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G. Nature 452, 116-119. (Pubitemid 351355093)
17. Chiu, Y.L., Witkowska, H.E., Hall, S.C., Santiago, M., Soros, V.B., Esnault, C., Heidmann, T., and Greene, W.C. (2006). High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition. Proc. Natl. Acad. Sci. USA 103, 15588-15593. (Pubitemid 44625636)
18. Conticello, S.G. (2008). The AID/APOBEC family of nucleic acid mutators. Genome Biol. 9, 229.
19. Derse, D., Hill, S.A., Princler, G., Lloyd, P., and Heidecker, G. (2007). Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsid. Proc. Natl. Acad. Sci. USA 104, 2915-2920. (Pubitemid 46327978)
20. Feng, Y. and Chelico, L. (2011). Intensity of deoxycytidine deamination of HIV-1 proviral DNA by the retroviral restriction factor APOBEC3G is mediated by the noncatalytic domain. J. Biol. Chem. 286, 11415-11426.
21. Friew, Y.N., Boyko, V., Hu, W.S., and Pathak, V.K. (2009). Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA. Retrovirology 6, 56.
22. Furukawa, A., Nagata, T., Matsugami, A., Habu, Y., Sugiyama, R., Hayashi, F., Kobayashi, N., Yokoyama, S., Takaku, H., and Katahira, M. (2009). Structure, interaction and real-time monitoring of the enzymatic reaction of wild-type APOBEC3G. EMBO J. 28, 440-451.
23. Gallois-Montbrun, S., Kramer, B., Swanson, C.M., Byers, H., Lynham, S., Ward, M., and Malim, M.H. (2007). Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J. Virol. 81, 2165-2178.
24. Gallois-Montbrun, S., Holmes, R.K., Swanson, C.M., Fernandez-Ocana, M., Byers, H.L., Ward, M.A., and Malim, M.H. (2008). Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins. J. Virol. 82, 5636-5642. (Pubitemid 351705270)
25. Hache, G., Liddament, M.T., and Harris, R.S. (2005). The retroviral hypermutation specificity of APOBEC3F and APOBEC3G is governed by the C-terminal DNA cytosine deaminase domain. J. Biol. Chem. 280, 10920-10924. (Pubitemid 40418393)
26. Harjes, E., Gross, P.J., Chen, K.M., Lu, Y., Shindo, K., Nowarski, R., Gross, J.D., Kotler, M., Harris, R.S., and Matsuo, H. (2009). An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model. J. Mol. Biol 389, 819-832.
27. Harris, R.S., Petersen-Mahrt, S.K., and Neuberger, M.S. (2002). RNA editing enzyme APOBEC1 and some of its homologs can act as DNA mutators. Mol. Cell 10, 1247-1253. (Pubitemid 35453840)
28. Holden, L.G., Prochnow, C., Chang, Y.P., Bransteitter, R., Chelico, L., Sen, U., Stevens, R.C., Goodman, M.F., and Chen, X.S. (2008). Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications. Nature 456, 121-124.
29. Huthoff, H., Autore, F., Gallois-Montbrun, S., Fraternali, F., and Malim, M.H. (2009). RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1. PLoS Pathog. 5, e1000330.
30. Iwatani, Y., Takeuchi, H., Strebel, K., and Levin, J.G. (2006). Biochemical activities of highly purified, catalytically active human APOBEC3G: correlation with antiviral effect. J. Virol. 80, 5992-6002. (Pubitemid 43849177)
31. Jager, S., Kim, D.Y., Hultquist, J.F., Shindo, K., LaRue, R.S., Kwon, E., Li, M., Anderson, B.D., Yen, L., Stanley, D., et al. (2012). Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. Nature 481, 371-375.
32. Jaguva Vasudevan, A.A., Perkovic, M., Bulliard, Y., Cichutek, K., Trono, D., Haussinger, D., and Munk, C. (2013). Prototype foamy virus bet impairs the dimerization and cytosolic solubility of human APOBEC3G. J. Virol. 2013 Jun 12. [Epub ahead of print].
33. Jarmuz, A., Chester, A., Bayliss, J., Gisbourne, J., Dunham, I., Scott, J., and Navaratnam, N. (2002). An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79, 285-296. (Pubitemid 34211936)
34. Kitamura, S., Ode, H., Nakashima, M., Imahashi, M., Naganawa, Y., Kurosawa, T., Yokomaku, Y., Yamane, T., Watanabe, N., Suzuki, A., et al. (2012). The APOBEC3C crystal structure and the interface for HIV-1 Vif binding. Nat. Struct. Mol. Biol 19, 1005-1010.
35. Kolokithas, A., Rosenke, K., Malik, F., Hendrick, D., Swanson, L., Santiago, M.L., Portis, J.L., Hasenkrug, K.J., and Evans, L.H. (2010). The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3. J. Virol. 84, 10933-10936.
36. Kozak, S.L., Marin, M., Rose, K.M., Bystrom, C., and Kabat, D. (2006). The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J. Biol. Chem. 281, 29105-29119. (Pubitemid 44507054)
37. Kreisberg, J.F., Yonemoto, W., and Greene, W.C. (2006). Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation. J. Exp. Med. 203, 865-870.
38. Krissinel, E. and Henrick, K. (2007). Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774-797. (Pubitemid 47321791)
39. LaRue, R.S., Jonsson, S.R., Silverstein, K.A., Lajoie, M., Bertrand, D., El-Mabrouk, N., Hotzel, I., Andresdottir, V., Smith, T.P., and Harris, R.S. (2008). The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. Mol. Biol. 9, 104.
40. LaRue, R.S., Andresdottir, V., Blanchard, Y., Conticello, S.G., Derse, D., Emerman, M., Greene, W.C., Jonsson, S.R., Landau, N.R., Löchelt, M., et al. (2009). Guidelines for naming nonprimate APOBEC3 genes and proteins. J. Virol. 83, 494-497.
41. Li, M., Shandilya, S.M., Carpenter, M.A., Rathore, A., Brown, W.L., Perkins, A.L., Harki, D.A., Solberg, J., Hook, D.J., Pandey, K.K., et al. (2012). First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G. ACS Chem. Biol. 7, 506-517.
42. Löchelt, M., Romen, F., Bastone, P., Muckenfuss, H., Kirchner, N., Kim, Y.B., Truyen, U., Rosler, U., Battenberg, M., Saib, A., et al. (2005). The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc. Natl. Acad. Sci. USA 102, 7982-7987. (Pubitemid 40781049)
43. Mariani, R., Chen, D., Schröfelbauer, B., Navarro, F., König, R., Bollman, B., Münk, C., Nymark-McMahon, H., and Landau, N.R. (2003). Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 114, 21-31. (Pubitemid 36859838)
44. Marin, M., Rose, K.M., Kozak, S.L., and Kabat, D. (2003). HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat. Med. 9, 1398-1403. (Pubitemid 37466189)
45. Mehle, A., Goncalves, J., Santa-Marta, M., McPike, M., and Gabuzda, D. (2004). Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation. Genes Dev. 18, 2861-2866. (Pubitemid 39602304)
46. Münk, C., Beck, T., Zielonka, J., Hotz-Wagenblatt, A., Chareza, S., Battenberg, M., Thielebein, J., Cichutek, K., Bravo, I.G., O'Brien, S.J., et al. (2008). Functions, structure, and read-through alternative splicing of feline APOBEC3 genes. Genome Biol. 9, R48.
47. Münk, C., Jensen, B.E., Zielonka, J., Häussinger, D., and Kamp, C. (2012a). Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif protein. Viruses 4, 3132-3161.
48. Münk, C., Willemsen, A., and Bravo, I.G. (2012b). An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals. BMC. Evol. Biol 12, 71.
49. Navarro, F., Bollman, B., Chen, H., König, R., Yu, Q., Chiles, K., and Landau, N.R. (2005). Complementary function of the two catalytic domains of APOBEC3G. Virology 333, 374-386. (Pubitemid 40250119)
50. Niewiadomska, A.M., Tian, C., Tan, L., Wang, T., Sarkis, P.T., and Yu, X.F. (2007). Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecularmass- complex formation or P-body association. J. Virol. 81, 9577-9583. (Pubitemid 47311504)
51. Nik-Zainal, S., Alexandrov, L.B., Wedge, D.C., Van, L.P., Greenman, C.D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L.A., et al. (2012). Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979-993.
52. Nowarski, R. and Kotler, M. (2013). APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion. Cancer Res. 73, 3494-3498.
53. Nowarski, R., Britan-Rosich, E., Shiloach, T., and Kotler, M. (2008). Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase. Nat. Struct. Mol. Biol. 15, 1059-1066.
54. Ooms, M., Krikoni, A., Kress, A.K., Simon, V., and Münk, C. (2012). APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1. J. Virol. 86, 6097-6108.
55. Perkovic, M., Schmidt, S., Marino, D., Russell, R.A., Stauch, B., Hofmann, H., Kopietz, F., Kloke, B.P., Zielonka, J., Strover, H., et al. (2009). Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J. Biol. Chem. 284, 5819-5826.
56. Prochnow, C., Bransteitter, R., Klein, M.G., Goodman, M.F., and Chen, X.S. (2007). The APOBEC-2 crystal structure and functional implications for the deaminase AID. Nature 445, 447-451. (Pubitemid 46160914)
57. Rausch, J.W., Chelico, L., Goodman, M.F., and Le Grice, S.F. (2009). Dissecting APOBEC3G substrate specificity by nucleoside analog interference. J. Biol. Chem. 284, 7047-7058.
58. Roberts, S.A., Sterling, J., Thompson, C., Harris, S., Mav, D., Shah, R., Klimczak, L.J., Kryukov, G.V., Malc, E., Mieczkowski, P.A., et al. (2012). Clustered mutations in yeast and in human cancers can arise from damaged long single-strand DNA regions. Mol. Cell 46, 424-435.
59. Russell, R.A., Wiegand, H.L., Moore, M.D., Schafer, A., McClure, M.O., and Cullen, B.R. (2005). Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J. Virol. 79, 8724-8731. (Pubitemid 40934783)
60. Salter, J.D., Krucinska, J., Raina, J., Smith, H.C., and Wedekind, J.E. (2009). A hydrodynamic analysis of APOBEC3G reveals a monomer-dimer-tetramer self-association that has implications for anti-HIV function. Biochemistry 48, 10685-10687.
61. Schumacher, A.J., Hache, G., MacDuff, D.A., Brown, W.L., and Harris, R.S. (2008). The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction. J. Virol. 82, 2652-2660. (Pubitemid 351329156)
62. Shandilya, S.M., Nalam, M.N., Nalivaika, E.A., Gross, P.J., Valesano, J.C., Shindo, K., Li, M., Munson, M., Royer, W.E., Harjes, E., et al. (2010). Crystal structure of the APOBEC3G catalytic domain reveals potential oligomerization interfaces. Structure 18, 28-38.
63. Sheehy, A.M., Gaddis, N.C., Choi, J.D., and Malim, M.H. (2002). Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418, 646-650.
64. Sheehy, A.M., Gaddis, N.C., and Malim, M.H. (2003). The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat. Med. 9, 1404-1407. (Pubitemid 37466190)
65. Shlyakhtenko, L.S., Lushnikov, A.Y., Li, M., Lackey, L., Harris, R.S., and Lyubchenko, Y.L. (2011). Atomic force microscopy studies provide direct evidence for dimerization of the HIV restriction factor APOBEC3G. J. Biol. Chem. 286, 3387-3395.
66. Shlyakhtenko, L.S., Lushnikov, A.Y., Miyagi, A., Li, M., Harris, R.S., and Lyubchenko, Y.L. (2012). Nanoscale structure and dynamics of ABOBEC3G complexes with single-stranded DNA. Biochemistry 51, 6432-6440.
67. Smith, J.L. and Pathak, V.K. (2010). Identification of specific determinants of human APOBEC3F, APOBEC3C, and APOBEC3DE and African green monkey APOBEC3F that interact with HIV-1 Vif. J. Virol. 84, 12599-12608.
68. Song, C., Sutton, L., Johnson, M.E., D'Aquila, R.T., and Donahue, J.P. (2012). Signals in APOBEC3F N-terminal and C-terminal deaminase domains each contribute to encapsidation in HIV-1 virions and are both required for HIV-1 restriction. J. Biol. Chem. 287, 16965-16974.
69. Soros, V.B., Yonemoto, W., and Greene, W.C. (2007). Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H. PLoS. Pathog. 3, e15.
70. Stauch, B., Hofmann, H., Perkovic, M., Weisel, M., Kopietz, F., Cichutek, K., Münk, C., and Schneider, G. (2009). Model structure of APOBEC3C reveals a binding pocket modulating ribonucleic acid interaction required for encapsidation. Proc. Natl. Acad. Sci. USA 106, 12079-12084.
71. Stavrou, S., Nitta, T., Kotla, S., Ha, D., Nagashima, K., Rein, A.R., Fan, H., and Ross, S.R. (2013). Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex. Proc. Natl. Acad. Sci. USA 110, 9078-9083. doi: 10.1073/pnas.1217399110. [Epub 2013 May 13].
72. Strebel, K. and Khan, M.A. (2008). APOBEC3G encapsidation into HIV-1 virions: which RNA is it? Retrovirology 5, 55.
73. Taylor, B.J., Nik-Zainal, S., Wu, Y.L., Stebbings, L.A., Raine, K., Campbell, P.J., Rada, C., Stratton, M.R., and Neuberger, M.S. (2013). DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis. Elife 2, e00534.
74. Teh, A.H., Kimura, M., Yamamoto, M., Tanaka, N., Yamaguchi, I., and Kumasaka, T. (2006). The 1.48 A resolution crystal structure of the homotetrameric cytidine deaminase from mouse. Biochemistry 45, 7825-7833. (Pubitemid 44185499)
75. Wang, T., Zhang, W., Tian, C., Liu, B., Yu, Y., Ding, L., Spearman, P., and Yu, X.F. (2008). Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C. Virology 377, 71-79.
76. Wedekind, J.E., Gillilan, R., Janda, A., Krucinska, J., Salter, J.D., Bennett, R.P., Raina, J., and Smith, H.C. (2006). Nanostructures of APOBEC3G support a hierarchical assembly model of high molecular mass ribonucleoprotein particles from dimeric subunits. J. Biol. Chem. 281, 38122-38126. (Pubitemid 46041936)
77. Wissing, S., Galloway, N.L., and Greene, W.C. (2010). HIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factors. Mol. Aspects Med. 31, 383-397.
78. Xiang, S., Short, S.A., Wolfenden, R., and Carter, C.W., Jr. (1997). The structure of the cytidine deaminase-product complex provides evidence for efficient proton transfer and ground-state destabilization. Biochemistry 36, 4768-4774. (Pubitemid 27180957)
79. Yu, X., Yu, Y., Liu, B., Luo, K., Kong, W., Mao, P., and Yu, X.F. (2003). Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science 302, 1056-1060. (Pubitemid 37386201)
80. Yu, Y., Xiao, Z., Ehrlich, E.S., Yu, X., and Yu, X.F. (2004). Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. Genes Dev. 18, 2867-2872. (Pubitemid 39602305)
81. Zhang, K.L., Mangeat, B., Ortiz, M., Zoete, V., Trono, D., Telenti, A., and Michielin, O. (2007). Model structure of human APOBEC3G. PLoS One. 2, e378.
82. Zhang, W., Du, J., Evans, S.L., Yu, Y., and Yu, X.F. (2012). T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction. Nature 481, 376-379.